Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AGRONOMICS LIMITED Net Asset Value 2021

Jul 30, 2021

7474_nav_2021-07-30_1e9b763b-2685-4a47-bd9d-f316126acd78.html

Net Asset Value

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 1460H

Agronomics Limited

30 July 2021

This announcement replaces the announcement with RNS number 0945H made at 12.02 today and which was published with the incorrect RNS headline "Net Asset Value calculation to 31 June 2021" whereas the correct headline is "Net Asset Value calculation to 30 June 2021".     All other text remains the same.

30 July 2021

Agronomics Limited

("Agronomics" or the "Company")

Net Asset Value calculation to 30 June 2021

Agronomics Limited (AIM:ANIC), a leading London listed company in alternative proteins with a focus on cellular agriculture and cultivated meat, announces that its unaudited Net Asset Valuation ("NAV") calculation as at closing on 30 June 2021 was 11.71 pence per share, including un-invested cash of £62.4 million. Net Assets stand at £93.6 million, including investments of £32.5 million. This quarter's NAV per share represents an increase of 88.2% from the previous quarter's NAV of 6.22 pence per share.

The share price of 23.7 pence at the 30 June 2021 close represents a premium of 118.8% to the NAV per share.  Under IFRS, the Company's unquoted investments are carried at cost or the most recent priced funding round.

Richard Reed, Chairman of Agronomics, commented: -

"We are very grateful for the strong support we have received from new and existing shareholders. Our assets have continued to perform well and the broader developments across our holdings in the period have further strengthened our position as the largest listed company focused on the field of cellular agriculture."

The highlight for the Company was the successful completion of an over-subscribed fundraise during May 2021, raising net proceeds of £62.8 million and issuing in total 297,727,274 new ordinary shares.

During April 2021, Solar Foods Oy received a EUR10 million capital loan from the Finnish Climate Fund to build a new demonstration facility in Finland.

During April 2021, Legendairy Foods GmbH completed its rebranding to Formo as a consumer-facing brand, at the forefront of the future of cultivated dairy. Formo is the leading European player in the precision fermentation space, focusing on animal-free dairy products.

On 13 May 2021, the Company completed a secondary purchase of 117 shares in Meatable B.V., increasing its stake to 5.84% on a fully diluted basis.

On 28 May 2021, CellX completed its Seed Funding Round, resulting in the SAFE investment held by the Company converting into 230,681 preferred shares, leading to a 500% uplift in to the $50,000 investment.

On 24 June 2021, Agronomics sold its entire holding in Insilico Medicine, Inc, for total proceeds of $669,775, representing an IRR 54%. Insilico Medicine was a legacy portfolio holding, acquired between June 2017 and July 2018.

Any fees due to Shellbay Limited will be subject to the audited net asset value of the Company for the 30 June 2021 year-end.

Unaudited to

30 June 2021

£
Fixed Assets
Investments 32,504,962
Current Assets
Uninvested Cash 62,436,497
Sundry Debtors 428,832
Current Liabilities
Trade and Other Creditors (143,336)
Future investment commitment (1,592,178)
93,634,777
Capital and Reserves
Share Capital 799
Share Premium 91,458,482
Retained Earnings 2,175,496
93,634,777
Shares in Issue 799,606,383
Net Asset Value per share 11.71 pence

The quoted investments within the portfolio are valued under IFRS at bid price.

Portfolio Details

Investments as at 30 June 2021 Value (£) % of Total Portfolio
Quoted holdings 660,206 2.0%
Unquoted holdings 30,252,578 93.1%
Committed future investment 1,592,178 4.9%
Total 32,504,962 100%

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ('MAR').  Upon the publication of this announcement via a Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain. 

For further information please contact:

Agronomics

Limited
Beaumont

Cornish Limited
Cenkos

Securities Plc
Peterhouse Capital

Limited
TB Cardew
The Company Nomad Joint Broker Joint Broker Public Relations
Richard Reed

Denham Eke
Roland Cornish

James Biddle
Giles Balleny

Michael Johnson
Lucy Williams

Charles Goodfellow
Ed Orlebar

Joe McGregor
+44 (0) 1624 639396

[email protected]
+44 (0) 207 628 3396 +44 (0) 207 397 8900 +44 (0) 207 469 0936 +44 (0) 20 7930 0777

+44 (0) 7738 724 630

[email protected]

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NAVWPUGWMUPGGQU